Enrichment of human embryonic stem cell-derived V3 interneurons using an Nkx2-2 gene-specific reporter.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 02 2023
Historique:
received: 19 08 2022
accepted: 31 01 2023
pubmed: 4 2 2023
medline: 8 2 2023
entrez: 3 2 2023
Statut: epublish

Résumé

V3 spinal interneurons are a key element of the spinal circuits, which control motor function. However, to date, there are no effective ways of deriving a pure V3 population from human pluripotent stem cells. Here, we report a method for differentiation and isolation of spinal V3 interneurons, combining extrinsic factor-mediated differentiation and magnetic activated cell sorting. We found that differentiation of V3 progenitors can be enhanced with a higher concentration of Sonic Hedgehog agonist, as well as culturing cells in 3D format. To enable V3 progenitor purification from mixed differentiation cultures, we developed a transgene reporter, with a part of the regulatory region of V3-specific gene Nkx2-2 driving the expression of a membrane marker CD14. We found that in human cells, NKX2-2 initially exhibited co-labelling with motor neuron progenitor marker, but V3 specificity emerged as the differentiation culture progressed. At these later differentiation timepoints, we were able to enrich V3 progenitors labelled with CD14 to ~ 95% purity, and mature them to postmitotic V3 interneurons. This purification tool for V3 interneurons will be useful for in vitro disease modeling, studies of normal human neural development and potential cell therapies for disorders of the spinal cord.

Identifiants

pubmed: 36737643
doi: 10.1038/s41598-023-29165-z
pii: 10.1038/s41598-023-29165-z
pmc: PMC9898512
doi:

Substances chimiques

Hedgehog Proteins 0
Homeobox Protein Nkx-2.2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2008

Subventions

Organisme : Wellcome Trust
ID : 108874/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025865/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V002783/1
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Dev Cell. 2006 Sep;11(3):325-37
pubmed: 16950124
Nat Commun. 2011;2:274
pubmed: 21505430
Neuron. 2008 Oct 9;60(1):84-96
pubmed: 18940590
Development. 2014 Feb;141(4):784-94
pubmed: 24496616
Cold Spring Harb Symp Quant Biol. 1997;62:451-66
pubmed: 9598380
Biomaterials. 2018 Apr;162:208-223
pubmed: 29459311
Adv Biosyst. 2019 Jul;3(7):
pubmed: 31428672
Stem Cells Dev. 2015 Nov 15;24(22):2723-32
pubmed: 26165862
J Neurotrauma. 2017 Nov 1;34(21):3058-3065
pubmed: 28548606
Cell Rep. 2018 May 1;23(5):1286-1300.e7
pubmed: 29719245
Neuron. 2001 Sep 13;31(5):791-807
pubmed: 11567617
Stem Cells. 2014 May;32(5):1230-8
pubmed: 24497442
Stem Cells Dev. 2021 Aug 15;30(16):816-829
pubmed: 34139881
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4969-4974
pubmed: 28438991
Cell. 2002 Aug 9;110(3):385-97
pubmed: 12176325
J Neurosci. 2002 Nov 15;22(22):9961-71
pubmed: 12427853
Stem Cells Dev. 2014 Jan 1;23(1):5-15
pubmed: 24007338
Neuron. 2014 Apr 2;82(1):138-50
pubmed: 24698273
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Elife. 2017 Feb 14;6:
pubmed: 28195039
Development. 2010 Dec;137(24):4249-60
pubmed: 21068056
ACS Med Chem Lett. 2012 Oct 11;3(10):808-813
pubmed: 23074541
Nat Biotechnol. 2017 Feb;35(2):154-163
pubmed: 28112759
Nat Rev Neurosci. 2009 Jul;10(7):507-18
pubmed: 19543221
J Neurophysiol. 2017 Dec 1;118(6):2956-2974
pubmed: 28855288
J Neurosci. 2013 Nov 20;33(47):18553-65
pubmed: 24259577
Development. 2021 Aug 1;148(15):
pubmed: 34351410
Nat Biotechnol. 2009 Sep;27(9):851-7
pubmed: 19680244
Nat Commun. 2015 Mar 25;6:6626
pubmed: 25806427
Cell. 1997 Jul 11;90(1):169-80
pubmed: 9230312
Exp Neurol. 2017 Jan;287(Pt 2):192-204
pubmed: 27456268
Dev Dyn. 2019 Jan;248(1):78-87
pubmed: 30324766
Sci Adv. 2021 Sep 10;7(37):eabi8787
pubmed: 34516770
Stem Cells Dev. 2014 Aug 1;23(15):1765-76
pubmed: 24650073
J Neurosci. 2021 Apr 14;41(15):3432-3445
pubmed: 33637562
Science. 2014 Apr 4;344(6179):94-7
pubmed: 24700859
Front Cell Neurosci. 2019 Nov 20;13:516
pubmed: 31824266
Stem Cells. 2008 Feb;26(2):496-504
pubmed: 18024421
Nature. 1999 Apr 15;398(6728):622-7
pubmed: 10217145
Nat Protoc. 2019 Nov;14(11):3033-3058
pubmed: 31628445
Prog Neurobiol. 2003 Jul;70(4):347-61
pubmed: 12963092
J Neurotrauma. 2018 Dec 15;35(24):2883-2903
pubmed: 29873284

Auteurs

Ieva Berzanskyte (I)

Centre for Gene Therapy and Regenerative Medicine, Centre for Developmental Neurobiology, MRC Centre for Neurodevelopmental Disorders, King's College London, 28th Floor Tower Wing, Guy's Campus, Great Maze Pond, London, SE1 9RT, UK. ievab@mrc-lmb.cam.ac.uk.
The Wolfson Centre for Age-Related Diseases, King's College London, London, UK. ievab@mrc-lmb.cam.ac.uk.

Federica Riccio (F)

Centre for Gene Therapy and Regenerative Medicine, Centre for Developmental Neurobiology, MRC Centre for Neurodevelopmental Disorders, King's College London, 28th Floor Tower Wing, Guy's Campus, Great Maze Pond, London, SE1 9RT, UK.

Carolina Barcellos Machado (CB)

Centre for Gene Therapy and Regenerative Medicine, Centre for Developmental Neurobiology, MRC Centre for Neurodevelopmental Disorders, King's College London, 28th Floor Tower Wing, Guy's Campus, Great Maze Pond, London, SE1 9RT, UK.

Elizabeth J Bradbury (EJ)

The Wolfson Centre for Age-Related Diseases, King's College London, London, UK.

Ivo Lieberam (I)

Centre for Gene Therapy and Regenerative Medicine, Centre for Developmental Neurobiology, MRC Centre for Neurodevelopmental Disorders, King's College London, 28th Floor Tower Wing, Guy's Campus, Great Maze Pond, London, SE1 9RT, UK. ivo.lieberam@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH